Results 201 to 210 of about 70,730 (308)

Clinical Pharmacology Quality Assurance Program for Global HIV and Co‐Infection Drug Development

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1205-1215, May 2026.
When the acquired immunodeficiency syndrome emerged in the 1980s, the United States National Institutes of Health established research networks to conduct clinical trials with the pharmaceutical industry to identify effective antiretroviral therapeutics.
Robin DiFrancesco   +17 more
wiley   +1 more source

Borrelia burgdorferi sensu lato Employs Several Escape Mechanisms to Bypass the Human Defense System

open access: yesEuropean Journal of Immunology, Volume 56, Issue 5, May 2026.
Integrated overview of host defense and immune evasion in Lyme Borreliosis. Bbsl evades immunity through tick saliva‐mediated suppression of innate defenses, TLR2/NOD2‐driven cytokine dysregulation, and interference with JAK/STAT and CIITA‐dependent antigen presentation.
Zara Karami   +2 more
wiley   +1 more source

Structural basis for EtfD-mediated coupling of β-oxidation and the respiratory chain in mycobacteria. [PDF]

open access: yesEMBO J
Courbon GM   +5 more
europepmc   +1 more source

Vitamin D Status and Supplementation and the Functional Outcomes of Human Musculoskeletal Tissues: A Stratified Systematic Review

open access: yesHealth Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aim This systematic review examined associations between vitamin D status and/or supplementation and functional outcomes (e.g., strength, performance, falls), with secondary reporting of biomechanical endpoints of human muscle, tendon, and bone.
Mohammad Soltani   +2 more
wiley   +1 more source

Concomitant Multidrug-resistant Pulmonary Tuberculosis and Susceptible Tuberculous Meningitis

open access: yesEmerging Infectious Diseases, 2014
Christine Bernard   +9 more
doaj   +1 more source

Costs of Extrapulmonary Nontuberculous Mycobacteria Disease, Denmark, 2005-2017. [PDF]

open access: yesEmerg Infect Dis
Dahl VN   +5 more
europepmc   +1 more source

Molecular Mechanisms of Resistance and Treatment Efficacy of Delamanid Against Mycobacterium tuberculosis: A Systematic Review

open access: yesHealth Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims Tuberculosis (TB) remains a major global health problem, and treatment progress is increasingly threatened by rising multidrug‐resistant tuberculosis (MDR‐TB). Delamanid (DLM), a nitroimidazole drug, has shown good efficacy and safety against both drug‐susceptible and drug‐resistant Mycobacterium tuberculosis (Mtb) strains.
Md. Mahmudul Islam   +19 more
wiley   +1 more source

Nontuberculous Mycobacteria Infections in Children: A Clinical Overview of Diagnosis and Management. [PDF]

open access: yesMicroorganisms
Li Pomi A   +7 more
europepmc   +1 more source

Case Report of an Infectious Aortic Aneurysm Following Intravesical Bacillus Calmette‐Guérin Therapy After Transurethral Resection of a Bladder Tumor

open access: yesIJU Case Reports, Volume 9, Issue 3, May 2026.
ABSTRACT Introduction Intravesical Bacillus Calmette‐Guérin (BCG) therapy is an established treatment for non‐muscle‐invasive bladder cancer. Although systemic BCG infection is rare, infectious aortic aneurysm is a potentially fatal complication.
Daisuke Muto   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy